321 related articles for article (PubMed ID: 23219472)
1. The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents.
Egecioglu E; Steensland P; Fredriksson I; Feltmann K; Engel JA; Jerlhag E
Psychoneuroendocrinology; 2013 Aug; 38(8):1259-70. PubMed ID: 23219472
[TBL] [Abstract][Full Text] [Related]
2. Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents.
Vallöf D; Kalafateli AL; Jerlhag E
Psychoneuroendocrinology; 2019 May; 103():284-295. PubMed ID: 30771711
[TBL] [Abstract][Full Text] [Related]
3. The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice.
Egecioglu E; Engel JA; Jerlhag E
PLoS One; 2013; 8(10):e77284. PubMed ID: 24204788
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 receptors within the nucleus of the solitary tract regulate alcohol-mediated behaviors in rodents.
Vallöf D; Vestlund J; Jerlhag E
Neuropharmacology; 2019 May; 149():124-132. PubMed ID: 30772374
[TBL] [Abstract][Full Text] [Related]
5. Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior.
Anderberg RH; Anefors C; Bergquist F; Nissbrandt H; Skibicka KP
Physiol Behav; 2014 Sep; 136():135-44. PubMed ID: 24560840
[TBL] [Abstract][Full Text] [Related]
6. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
Dickson SL; Shirazi RH; Hansson C; Bergquist F; Nissbrandt H; Skibicka KP
J Neurosci; 2012 Apr; 32(14):4812-20. PubMed ID: 22492036
[TBL] [Abstract][Full Text] [Related]
7. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice.
Sørensen G; Reddy IA; Weikop P; Graham DL; Stanwood GD; Wortwein G; Galli A; Fink-Jensen A
Physiol Behav; 2015 Oct; 149():262-8. PubMed ID: 26072178
[TBL] [Abstract][Full Text] [Related]
8. Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1.
Jerlhag E
Brain Res; 2020 Jan; 1727():146562. PubMed ID: 31759971
[TBL] [Abstract][Full Text] [Related]
9. The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents.
Vallöf D; Maccioni P; Colombo G; Mandrapa M; Jörnulf JW; Egecioglu E; Engel JA; Jerlhag E
Addict Biol; 2016 Mar; 21(2):422-37. PubMed ID: 26303264
[TBL] [Abstract][Full Text] [Related]
10. The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice.
Egecioglu E; Engel JA; Jerlhag E
PLoS One; 2013; 8(7):e69010. PubMed ID: 23874851
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice.
Jerlhag E; Engel JA
Drug Alcohol Depend; 2011 Sep; 117(2-3):126-31. PubMed ID: 21310553
[TBL] [Abstract][Full Text] [Related]
12. Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward.
Shirazi RH; Dickson SL; Skibicka KP
PLoS One; 2013; 8(4):e61965. PubMed ID: 23613987
[TBL] [Abstract][Full Text] [Related]
13. A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models.
Rorick-Kehn LM; Ciccocioppo R; Wong CJ; Witkin JM; Martinez-Grau MA; Stopponi S; Adams BL; Katner JS; Perry KW; Toledo MA; Diaz N; Lafuente C; Jiménez A; Benito A; Pedregal C; Weiss F; Statnick MA
Alcohol Clin Exp Res; 2016 May; 40(5):945-54. PubMed ID: 27084498
[TBL] [Abstract][Full Text] [Related]
14. The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice.
Vallöf D; Vestlund J; Engel JA; Jerlhag E
PLoS One; 2016; 11(5):e0154477. PubMed ID: 27139195
[TBL] [Abstract][Full Text] [Related]
15. Brain Site-Specific Inhibitory Effects of the GLP-1 Analogue Exendin-4 on Alcohol Intake and Operant Responding for Palatable Food.
Colvin KJ; Killen HS; Kanter MJ; Halperin MC; Engel L; Currie PJ
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352692
[TBL] [Abstract][Full Text] [Related]
16. Effects of the GLP-1 Agonist Exendin-4 on Intravenous Ethanol Self-Administration in Mice.
Sørensen G; Caine SB; Thomsen M
Alcohol Clin Exp Res; 2016 Oct; 40(10):2247-2252. PubMed ID: 27579999
[TBL] [Abstract][Full Text] [Related]
17. The GLP-1 agonist exendin-4 attenuates self-administration of sweetened fat on fixed and progressive ratio schedules of reinforcement in rats.
Bernosky-Smith KA; Stanger DB; Trujillo AJ; Mitchell LR; España RA; Bass CE
Pharmacol Biochem Behav; 2016 Mar; 142():48-55. PubMed ID: 26701752
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.
Bornebusch AB; Fink-Jensen A; Wörtwein G; Seeley RJ; Thomsen M
eNeuro; 2019; 6(2):. PubMed ID: 31058214
[TBL] [Abstract][Full Text] [Related]
19. The glucagon-like peptide-1 receptor agonist, exendin-4, reduces sexual interaction behaviors in a brain site-specific manner in sexually naïve male mice.
Vestlund J; Jerlhag E
Horm Behav; 2020 Aug; 124():104778. PubMed ID: 32450068
[TBL] [Abstract][Full Text] [Related]
20. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice.
Talsania T; Anini Y; Siu S; Drucker DJ; Brubaker PL
Endocrinology; 2005 Sep; 146(9):3748-56. PubMed ID: 15932924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
